Source link : https://www.newshealth.biz/health-news/investigational-once-monthly-injectable-boosts-response-rate-in-acromegaly/
An investigational treatment for acromegaly — also known as gigantism — was safe and boosted biochemical control, according to final topline findings of the phase III ACROINNOVA 2 study. Meeting the primary endpoint of the 52-week, long-term safety and extension study, once-monthly octreotide subcutaneous depot (CAM2029) was well-tolerated and had a safety profile comparable to […]
Author : News Health
Publish date : 2024-07-23 21:13:25
Copyright for syndicated content belongs to the linked Source.
Categories